July 24, 2026

Industry Insights

ASCO Breakthrough, Singapore 2026: Advances in p53-Targeted Therapies

The first important progress in targeting p53 mutations happened in the 1980s and 1990s when...

Read More
Industry Insights

Clinical Trial Updates: Is Now the Appropriate Time to Consider Clinical Trial Matching?

(Discussions at ASCO Breakthrough, Singapore 2026) Translating clinical knowledge into effective bedside care means turning...

Read More